Orforglipron
Orforglipron is a non-peptide, small-molecule GLP-1 agonist designed for oral administration to activate the GLP-1 receptor.
- Orforglipron binds selectively to the GLP-1 receptor in research settings.
Specifications
- Form
- Sublingual Tablets
- Strength
- 6mg per tab/90ct/540mg, 12mg per tab/90ct/1080mg
AI Readiness
Good foundation, but some important product data is still missing.
74%